Your browser doesn't support javascript.
loading
Pilot study of the combination of sorafenib and fractionated irinotecan in pediatric relapse/refractory hepatic cancer (FINEX pilot study).
Keino, Dai; Yokosuka, Tomoko; Hirose, Ayana; Sakurai, Yukari; Nakamura, Wataru; Fujita, Sachio; Hayashi, Akiko; Miyagawa, Naoyuki; Iwasaki, Fuminori; Hamanoue, Satoshi; Yanagimachi, Masakatsu; Shiomi, Masae; Goto, Shoko; Kitagawa, Norihiko; Tanaka, Mio; Nozawa, Kumiko; Tanaka, Yukichi; Goto, Hiroaki.
Afiliação
  • Keino D; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Yokosuka T; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Hirose A; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Sakurai Y; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Nakamura W; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Fujita S; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Hayashi A; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Miyagawa N; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Iwasaki F; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Hamanoue S; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Yanagimachi M; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Shiomi M; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Goto S; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Kitagawa N; Division of Surgery, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Tanaka M; Division of Diagnostic Pathology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Nozawa K; Division of Radiology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Tanaka Y; Division of Diagnostic Pathology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Goto H; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Pediatr Blood Cancer ; 67(11): e28655, 2020 11.
Article em En | MEDLINE | ID: mdl-32798298
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Carcinoma Hepatocelular / Resistencia a Medicamentos Antineoplásicos / Neoplasias Hepáticas / Recidiva Local de Neoplasia Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Pediatr Blood Cancer Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Carcinoma Hepatocelular / Resistencia a Medicamentos Antineoplásicos / Neoplasias Hepáticas / Recidiva Local de Neoplasia Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Pediatr Blood Cancer Ano de publicação: 2020 Tipo de documento: Article